greeksoup/ stock research

Natera (NTRA) Q3 FY2026 earnings: revenue $794 million, up 34.1% on the year

Natera, Inc. (NTRA) reported revenue of $794 million for Q3 FY2026, the quarter ended 30 September 2026, up 34.1% on the same quarter a year earlier. Net income was -$60 million, and diluted earnings per share $-0.42. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.

Revenue
$794 million
+34.1% on the year · +5.5% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
-8.6%
-16.5% a year earlier
Q4 FY2024Q3 FY2026
Net income
-$60 million
Q4 FY2024Q3 FY2026
Diluted EPS
-$0.42
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 3 raised, 1 kept.

  • Revenue rose 34.1% year over year: Total revenues were $794.0 million, compared with $592.2 million a year earlier, up 34.1%. Management attributed the increase to higher volume and average selling price improvements.
  • Oncology tests grew 60.9%: Oncology tests processed were about 339,500, compared with about 211,000 a year earlier, an increase of 60.9%.
  • Clinical MRD units grew sequentially: Clinical molecular residual disease oncology units increased by 32,700 over the second quarter of 2026.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Revenue794753592+5.5%+34.1%
Research and development242228173+6.3%+39.8%
Selling, general and administrative334327309+2.0%+8.1%
Operating income-68.3-75.8-97.6
Operating margin-8.6%-10.1%-16.5%
Interest expense0.90.91.0+1.5%-13.6%
Pre-tax income-59.6-67.2-87.3
Income tax0.3-0.30.2+44.4%
Net income-59.9-67.0-87.5
Net margin-7.5%-8.9%-14.8%
Diluted EPS-$0.42-$0.47-$0.64
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow43.954.859.4-19.8%-26.0%
Capital expenditure38.763.422.4-39.0%+72.6%
Free cash flow5.3-8.637.0-85.8%
Free cash flow margin0.7%-1.1%6.2%
Cash from investing-38.9-63.4-19.9
Cash from financing0.712.21.9-94.4%-64.7%
Depreciation and amortisation20.418.89.3+8.5%+119.4%
Share-based compensation10610390.6+2.9%+17.1%
Diluted shares, weighted144m143m137m+0.5%+5.0%
Shares outstanding at period end144m144m138m+0.5%+5.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity1,8701,8211,252+2.6%+49.3%
Debt80.380.380.3+0.0%-0.1%
Operating lease liabilities143143104-0.3%+36.6%
Other liabilities656613385+7.1%+70.6%
Total liabilities and equity2,7482,6571,821+3.4%+50.9%
Fixed assets354318206+11.5%+71.4%
Goodwill141141n/a0.0%
Intangible assets353360n/a-2.0%
Investmentsn/an/a1.0
Securities held for sale or to maturityn/a1,092n/a
Cash and equivalents1,0971,0921,041+0.5%+5.4%
Receivables471422286+11.7%+64.6%
Inventory91.780.364.6+14.1%+41.9%
Other assets240n/a222+8.4%
Total assets2,7482,6571,821+3.4%+50.9%

Questions

What was Natera's revenue in Q3 FY2026?

Natera (NTRA) reported revenue of $794 million for Q3 FY2026, the quarter ended 30 September 2026, up 34.1% on the same quarter a year earlier.

How much did Natera earn in Q3 FY2026?

Net loss for Q3 FY2026 was $60 million, and the diluted loss per share $0.42.

When did Natera report Q3 FY2026 results?

Natera filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023 †Q2 FY2023Q3 FY2023Q4 FY2023 * †Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue173194198211217242261268311368413440476502547592666697753794
R&D71.880.482.665.587.982.378.277.283.088.689.196.9129129146173175211228242
SG&A147148149148144150153155161194198214235267311309291328327334
Operating income-140-137-143-119-142-138-112-111-84.5-74.3-43.9-39.3-64.7-79.2-110-97.6-22.8-93.5-75.8-68.3
Operating margin-81%-71%-72%-57%-65%-57%-43%-41%-27%-20%-11%-9%-14%-16%-20%-16%-3%-13%-10%-9%
Interest expense2.12.12.12.32.83.13.23.33.13.13.13.11.31.01.01.01.00.90.90.9
Pre-tax income-141-138-145-121-142-137-111-109-77.8-67.2-36.6-30.9-55.1-66.8-101-87.3-13.3-84.8-67.2-59.6
Net income-141-139-145-121-143-137-111-109-78.0-67.6-37.5-31.6-53.8-66.9-101-87.547.3-85.1-67.0-59.9
Net margin-81%-71%-73%-58%-66%-57%-42%-41%-25%-18%-9%-7%-11%-13%-18%-15%7%-12%-9%-8%
Diluted EPS-$1.52-$1.45-$1.50-$1.25-$1.37-$1.23-$0.97-$0.95-$0.63-$0.56-$0.30-$0.26-$0.41-$0.50-$0.74-$0.64$0.36-$0.60-$0.47-$0.42
Operating cash flow-98.7-137-111-102-81.1-81.1-78.4-29.6-58.127.04.051.852.944.537.659.473.940.254.843.9
Capital expenditure9.015.97.812.211.811.49.09.19.520.311.716.318.121.825.922.436.122.163.438.7
Free cash flow-108-153-119-114-93.0-92.5-87.4-38.7-67.76.7-7.735.534.822.611.737.037.818.0-8.65.3
Shares outstanding95m96m97m97m111m113m114m119m120m122m123m124m133m136m137m138m140m143m144m144m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.